Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

Clinical trial NCT04296864 · UNKNOWN

Trial details

NCT number: NCT04296864
Sponsor: Andover Eye Associates
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Keratoconjunctivitis

Start date: 2020-02-10
Primary completion: 2025-01-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.